English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Identification of common genetic risk variants for autism spectrum disorder

MPS-Authors
/persons/resource/persons180748

St Pourcain,  Beate
Language and Genetics Department, MPI for Psycholinguistics, Max Planck Society;
MRC Integrative Epidemiology Unit, University of Bristol;
Donders Institute for Brain, Cognition and Behaviour, External Organizations;
Population genetics of human communication, MPI for Psycholinguistics, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
Supplementary Material (public)

41588_2019_344_MOESM1_ESM.pdf
(Supplementary material), 4MB

Citation

Grove, J., Ripke, S., Als, T. D., Mattheisen, M., Walters, R., Won, H., et al. (2019). Identification of common genetic risk variants for autism spectrum disorder. Nature Genetics, 51, 431-444. doi:10.1038/s41588-019-0344-8.


Cite as: https://hdl.handle.net/21.11116/0000-0002-AF89-F
Abstract
Autism spectrum disorder (ASD) is a highly heritable and heterogeneous group of neurodevelopmental phenotypes diagnosed in more than 1% of children. Common genetic variants contribute substantially to ASD susceptibility, but to date no individual variants have been robustly associated with ASD. With a marked sample-size increase from a unique Danish population resource, we report a genome-wide association meta-analysis of 18,381 individuals with ASD and 27,969 controls that identified five genome-wide-significant loci. Leveraging GWAS results from three phenotypes with significantly overlapping genetic architectures (schizophrenia, major depression, and educational attainment), we identified seven additional loci shared with other traits at equally strict significance levels. Dissecting the polygenic architecture, we found both quantitative and qualitative polygenic heterogeneity across ASD subtypes. These results highlight biological insights, particularly relating to neuronal function and corticogenesis, and establish that GWAS performed at scale will be much more productive in the near term in ASD.